Ocugen (OCGN) Preferred Shares (2021 - 2024)

Ocugen (OCGN) posted Preferred Shares of $1000.0 for Q1 2024, little changed on a QoQ basis from $1000.0 in Q4 2023.

Ocugen (OCGN) Preferred Shares (2021 - 2024) Analysis & Trends

Ocugen's Preferred Shares history runs 4 years deep, the most recent figure standing at $1000.0 for Q1 2024.

Quarterly Preferred Shares changed N/A year-over-year to $1000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $1000.0 (changed N/A YoY) and the FY2023 annual result came in at $1000.0, changed N/A from the prior year.
Preferred Shares was $1000.0 for Q1 2024 at Ocugen, roughly flat from $1000.0 in the prior quarter.
Across five years, Preferred Shares topped out at $5.0 million in Q4 2021 and bottomed at $1000.0 in Q1 2021.
A 4-year average of $834166.7 and a median of $1000.0 in 2021 frame the typical range for Preferred Shares.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Ocugen	63.79 Mn	63.79 Mn	-	-

Download Data